Latigo Biotherapeutics (NASDAQ:LTGO) Major Shareholder Foresite Capital Management V, Acquires 140,000 Shares

Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) major shareholder Foresite Capital Management V, bought 140,000 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were bought at an average price of $18.00 per share, with a total value of $2,520,000.00. Following the purchase, the insider owned 2,008,024 shares in the company, valued at $36,144,432. The trade was a 7.49% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Latigo Biotherapeutics Stock Up 1.7%

Shares of LTGO stock traded up $0.31 during midday trading on Monday, hitting $18.56. 598,445 shares of the company were exchanged. Latigo Biotherapeutics, Inc. has a 52 week low of $17.22 and a 52 week high of $22.47.